The Romanian government is ending access to a crucial medication for hundreds of heart patients, leaving them facing life-threatening consequences. Patients have received notifications informing them that their state-funded prescriptions will be discontinued in two weeks. Without the medication, patients risk severe health deterioration and potential cardiac arrest. The financial burden of purchasing the drug privately is prohibitive for many, effectively denying them continued treatment. The number of affected patients exceeds 200, and the decision has sparked outrage and concern among medical professionals and patient advocacy groups. This policy change raises questions about healthcare accessibility and the prioritization of patient well-being within the Romanian healthcare system. Further details regarding the rationale behind the decision are currently emerging.